Advanced

Role of dietary beta-glucans in the prevention of the metabolic syndrome.

Cloetens, Lieselotte LU ; Ulmius, Matilda LU ; Johansson Persson, Anna LU ; Åkesson, Björn LU and Önning, Gunilla LU (2012) In Nutrition Reviews 70(8). p.444-458
Abstract
The present review examines the evidence regarding the effect of β-glucan on variables linked to the metabolic syndrome (MetS), including appetite control, glucose control, hypertension, and gut microbiota composition. Appetite control can indirectly influence MetS by inducing a decreased energy intake, and promising results for a β-glucan intake to decrease appetite have been found using gut hormone responses and subjective appetite indicators. Beta-glucan also improves the glycemic index of meals and beneficially influences glucose metabolism in patients with type 2 diabetes or MetS, as well as in healthy subjects. Furthermore, a blood-pressure-lowering effect of β-glucan in hypertensive subjects seems fairly well substantiated. The gut... (More)
The present review examines the evidence regarding the effect of β-glucan on variables linked to the metabolic syndrome (MetS), including appetite control, glucose control, hypertension, and gut microbiota composition. Appetite control can indirectly influence MetS by inducing a decreased energy intake, and promising results for a β-glucan intake to decrease appetite have been found using gut hormone responses and subjective appetite indicators. Beta-glucan also improves the glycemic index of meals and beneficially influences glucose metabolism in patients with type 2 diabetes or MetS, as well as in healthy subjects. Furthermore, a blood-pressure-lowering effect of β-glucan in hypertensive subjects seems fairly well substantiated. The gut microbiota composition might be an interesting target to prevent MetS, and preliminary results indicate the prebiotic potential of β-glucan. The evidence that β-glucan influences appetite control and gut microbiota in a positive way is still insufficient or difficult to interpret, and additional studies are needed in this field. Still, much evidence indicates that increased β-glucan intake could prevent MetS. Such evidence should encourage increased efforts toward the development of β-glucan-containing functional foods and promote the intake of β-glucan-rich foods, with the aim of reducing healthcare costs and disease prevalence. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Nutrition Reviews
volume
70
issue
8
pages
444 - 458
publisher
Wiley-Blackwell
external identifiers
  • wos:000306894900004
  • pmid:22835138
  • scopus:84864335174
ISSN
1753-4887
DOI
10.1111/j.1753-4887.2012.00494.x
language
English
LU publication?
yes
id
b76b3ae4-f98b-4eb8-960e-83bac13e9580 (old id 2966540)
date added to LUP
2012-09-03 12:28:50
date last changed
2017-11-19 03:59:35
@article{b76b3ae4-f98b-4eb8-960e-83bac13e9580,
  abstract     = {The present review examines the evidence regarding the effect of β-glucan on variables linked to the metabolic syndrome (MetS), including appetite control, glucose control, hypertension, and gut microbiota composition. Appetite control can indirectly influence MetS by inducing a decreased energy intake, and promising results for a β-glucan intake to decrease appetite have been found using gut hormone responses and subjective appetite indicators. Beta-glucan also improves the glycemic index of meals and beneficially influences glucose metabolism in patients with type 2 diabetes or MetS, as well as in healthy subjects. Furthermore, a blood-pressure-lowering effect of β-glucan in hypertensive subjects seems fairly well substantiated. The gut microbiota composition might be an interesting target to prevent MetS, and preliminary results indicate the prebiotic potential of β-glucan. The evidence that β-glucan influences appetite control and gut microbiota in a positive way is still insufficient or difficult to interpret, and additional studies are needed in this field. Still, much evidence indicates that increased β-glucan intake could prevent MetS. Such evidence should encourage increased efforts toward the development of β-glucan-containing functional foods and promote the intake of β-glucan-rich foods, with the aim of reducing healthcare costs and disease prevalence.},
  author       = {Cloetens, Lieselotte and Ulmius, Matilda and Johansson Persson, Anna and Åkesson, Björn and Önning, Gunilla},
  issn         = {1753-4887},
  language     = {eng},
  number       = {8},
  pages        = {444--458},
  publisher    = {Wiley-Blackwell},
  series       = {Nutrition Reviews},
  title        = {Role of dietary beta-glucans in the prevention of the metabolic syndrome.},
  url          = {http://dx.doi.org/10.1111/j.1753-4887.2012.00494.x},
  volume       = {70},
  year         = {2012},
}